Hindlimb Ischemia Model

HuaTeng Biotechnology provides high-fidelity Hindlimb Ischemia (HLI) models for PAD research. Expert femoral artery ligation in swine and rats with Laser Doppler Blood Flow (LDBF) validation and IHC analysis.

Model Name
Hindlimb Ischemia (HLI) Model
Animal Strains
Minipigs, Rats, Mice, Nude Mice (for Xenograft/Cell Therapy)
Model Description
The HLI model simulates clinical Peripheral Artery Disease (PAD) and Critical Limb Ischemia (CLI). By inducing controlled ischemia in the hindlimb, HuaTeng Biotechnology creates a robust microenvironment for studying therapeutic neovascularization and tissue salvage.

Applications

• Preclinical efficacy testing of pro-angiogenic factors and cell-based therapies.

• Validation of interventional devices for peripheral vascular revascularization.

• Molecular research on ischemia-induced muscle remodeling and collateral growth.

 

Modeling Methods

Precision Surgical Induction:

Small Animals: Standardized excision of the femoral artery from the inguinal ligament to the popliteal bifurcation to minimize spontaneous collateral bypass.

Large Animals (Swine): Clinically relevant ischemia induced via permanent surgical ligation or endovascular coil embolization.

 

Testing Items

Perfusion Analysis: Longitudinal Laser Doppler Blood Flow (LDBF) imaging to quantify blood flow recovery ratios.

Microvascular Quantification: IHC for CD31 (Capillary density) and α-SMA (Arteriolar density).

Histomorphometry: Capillary-to-muscle fiber ratio, H&E for myofiber atrophy, and Masson’s for interstitial fibrosis.

Functional Testing: Graded treadmill exercise and limb salvage scoring.

Send Us a Message

By using this form, you consent to HuaTeng Biotechnology storing and processing your personal data according to our [Privacy Policy] . We only use this information to resolve your inquiry.

Custom Hotline

+86 15217198166


Email

ht@htscience.com

Our WeChat

Our WeChat

Our WeChat

Scan to chat with us on WeChat!

Contact Us
Online Service
Hello! May I help you with something?